☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Zhejiang Doer Biologics
Zhejiang Doer Biologics Concludes Patient Recruitment in P-Ib/IIa Study of DR10624 Among Obese Individuals
July 5, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.